Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL31P58 (ribosomal protein L31 pseudogene 58) is a human processed pseudogene derived from the RPL31 protein-coding gene—one of several ribosomal protein pseudogenes dispersed throughout the genome. Pseudogenes are DNA sequences similar to known genes but are typically non-functional due to mutations acquired over evolutionary time. RPL31P58 is not expressed as protein, is not a therapeutic or diagnostic target, and does not participate in canonical molecular pathways. Its similarity in designation to protein-coding RPL31 can lead to confusion; care should be taken to distinguish the pseudogene (RPL31P58) from the functional ribosomal protein L31 gene (RPL31). RPL31P58 is not a functional protein or clinical drug target; it is a pseudogene with no evidence of protein expression, disease relevance, or therapeutic interaction. Its canonical name is "Ribosomal protein L31 pseudogene 58"; abbreviated as RPL31P58; and it should not be mistaken for the protein-coding ribosomal protein L31 gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 58 (RPL31P58).